AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system

AlderMed™ announced today it has entered into a three-year exclusive distribution agreement with Gulmay Medical™, manufacturer of the Xstrahl-100 therapy system. AlderMed provides the first mobile service to bring low-dose superficial radiotherapy treatment directly to the point-of-care. Together they strive to bring skin cancer patients a non-surgical, painless and effect treatment for non-melanoma skin cancer at their dermatology and cosmetic surgery office.

Applying the AlderMed SRTeam service model, along with the proprietary mobile x-ray technology of the Xstrahl-100™ system, dermatologists can offer their patients more choices when treating basal cell and squamous cell carcinomas. Not only does AlderMed deliver the treatment, it brings added expertise to the dermatologist by providing its own staff of radiation therapists, including access to consultation with medical physicists and radiation oncologists. When compared to other treatment modalities and surgical options, the Xstrahl-100 delivers high cure rates, low recurrence rates, no scarring and the convenience of treatment at the doctor's office.

"We are privileged to work with the global leader in X-ray therapy devices," said Larry Findleton, president at AlderMed. "We believe our service improves the quality of care for the patient. At the same time, increasing the value of the dermatologist's practice, by bringing a very affordable, mobile non-surgical skin cancer treatment service to their office."

"We are very impressed with the AlderMed SRTeam approach," says Adrian Treverton, Sales Director of Xstrahl. "Including the oncologist, medical physicist and radiation therapist as part of the treatment approach shares our vision of effective delivery of superficial radiation therapy."

Source:

AlderMed

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Xstrahl. (2023, June 05). AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20120430/AlderMed-enters-distribution-agreement-with-Gulmay-Medical-for-Xstrahl-100-therapy-system.aspx.

  • MLA

    Xstrahl. "AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20120430/AlderMed-enters-distribution-agreement-with-Gulmay-Medical-for-Xstrahl-100-therapy-system.aspx>.

  • Chicago

    Xstrahl. "AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system". News-Medical. https://www.news-medical.net/news/20120430/AlderMed-enters-distribution-agreement-with-Gulmay-Medical-for-Xstrahl-100-therapy-system.aspx. (accessed November 21, 2024).

  • Harvard

    Xstrahl. 2023. AlderMed enters distribution agreement with Gulmay Medical for Xstrahl-100 therapy system. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20120430/AlderMed-enters-distribution-agreement-with-Gulmay-Medical-for-Xstrahl-100-therapy-system.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Photoelectric therapy for non-melanoma skin cancer developed by Xstrahl